Opportunity Information: Apply for RFA HG 11 015

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Technology Development for High Throughput Functional Genomics (R43/44)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.172 Human Genome Research.
  • This funding opportunity was created on May 23, 2011 and posted on May 23, 2011.
  • Applicants must submit their applications by Aug 2, 2011. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $750,000.00 to eligible and selected applicants.
  • Eligible applicants include: Small businesses.
Apply for RFA HG 11 015

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health (NIH), issued this funding opportunity to support the creation of new and improved technologies that can rapidly and comprehensively find, confirm, and describe functional elements in eukaryotic genomes. The focus is on sequence-based functional elements, meaning DNA or RNA features whose roles can be inferred, tested, or measured directly from genomic sequence and related assays. In practical terms, the opportunity targets technology that makes it easier to identify and characterize things like regulatory DNA (enhancers, promoters, insulators), transcription factor binding sites, noncoding RNAs, chromatin-associated features, and other genomic elements that influence gene activity and cellular function. A major emphasis is high throughput and efficiency, so proposals are expected to push beyond small-scale, low-throughput approaches and instead enable comprehensive, scalable functional genomics workflows.

This announcement uses the SBIR R43/R44 mechanism, which is designed specifically for small businesses developing innovative technologies with strong potential for commercialization and broad research impact. Under the SBIR structure, Phase I (R43) typically supports early feasibility and proof-of-concept work, while Phase II (R44) supports more advanced research and development aimed at producing a more mature, validated technology. The eligible applicant pool is therefore limited to small businesses, and there is no cost sharing or matching requirement. The overall goal is to move functional genomics technology forward in ways that are practical, adoptable by the research community, and positioned to become robust products, platforms, or services.

Scientifically, the solicitation is framed as part of a larger coordinated effort. It shares the same scientific scope as companion announcements aimed at different applicant types and project styles: an R01 version for full research project grants (RFA-HG-11-013) and an R21 version for exploratory/developmental projects (RFA-HG-11-014). Together, these related opportunities were meant to stimulate a pipeline of innovation across academia and industry, with the SBIR track emphasizing small business-led development and translation. The announcement also explicitly connects to the technology development push that began in 2003 within the ENCODE project, reflecting NHGRI's long-term interest in building the tools needed to map functional DNA elements across the genome in a systematic, data-rich way.

Administratively, the opportunity is a discretionary NIH grant in the health funding category under CFDA 93.172 (Human Genome Research). The funding opportunity number is RFA-HG-11-015, titled "Technology Development for High Throughput Functional Genomics (R43/44)." It was posted on May 23, 2011, with an application closing date of August 2, 2011, and an archive date of September 2, 2011. The estimated total funding listed for the announcement is $750,000. Additional details and the full official text were made available through the NIH grants guide page linked in the notice, and NIH Office of Extramural Research webmaster contacts were provided for access or linking problems.

Frequently Asked Questions (FAQs)

What is this funding opportunity?

This is an NIH/NHGRI funding opportunity to support the creation of new and improved technologies for high throughput functional genomics in eukaryotic genomes. The funding opportunity number is RFA-HG-11-015, titled "Technology Development for High Throughput Functional Genomics (R43/44)."

Which NIH institute is offering the grant?

The opportunity was issued by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH).

What is the overall scientific goal?

The goal is to advance technologies that can rapidly and comprehensively find, confirm, and describe functional elements in eukaryotic genomes, with an emphasis on scalable, efficient, high throughput approaches.

What kinds of genomic features are considered "functional elements" under this opportunity?

The focus is on sequence-based functional elements (DNA or RNA features) whose roles can be inferred, tested, or measured directly from genomic sequence and related assays. Examples listed include regulatory DNA (enhancers, promoters, insulators), transcription factor binding sites, noncoding RNAs, chromatin-associated features, and other elements that influence gene activity and cellular function.

What does "sequence-based functional elements" mean in practical terms?

It refers to DNA or RNA features where function can be evaluated using genomic sequence information and assays tied to sequence, enabling identification and characterization directly from sequence and related measurements rather than relying on indirect or purely observational approaches.

What is meant by "high throughput" in this announcement?

The announcement emphasizes technologies that move beyond small-scale, low-throughput methods and instead enable comprehensive, scalable functional genomics workflows that can be applied broadly and efficiently.

What grant mechanism is being used?

This announcement uses the SBIR R43/R44 mechanism.

Who is eligible to apply?

The eligible applicant pool is limited to small businesses, consistent with the SBIR program structure described in the announcement.

What is the difference between Phase I and Phase II under this SBIR structure?

Phase I (R43) typically supports early feasibility and proof-of-concept work. Phase II (R44) typically supports more advanced research and development to produce a more mature, validated technology.

Is cost sharing or matching required?

No. The opportunity specifies there is no cost sharing or matching requirement.

What kinds of outcomes are expected from funded projects?

The announcement highlights outcomes that are practical and adoptable by the research community, and positioned to become robust products, platforms, or services with strong commercialization potential and broad research impact.

How does this SBIR opportunity relate to other NIH opportunities mentioned?

It shares the same scientific scope as companion announcements aimed at other applicant types and project styles: an R01 version (RFA-HG-11-013) and an R21 version (RFA-HG-11-014). The SBIR track emphasizes small business-led development and translation.

Does this opportunity connect to any larger coordinated efforts?

Yes. The solicitation is framed as part of a broader, coordinated effort to stimulate innovation across academia and industry, and it explicitly connects to the technology development push that began in 2003 within the ENCODE project.

What is the funding opportunity title and number?

The title is "Technology Development for High Throughput Functional Genomics (R43/44)" and the funding opportunity number is RFA-HG-11-015.

What is the CFDA number and program area?

The CFDA is 93.172, listed as Human Genome Research.

What type of grant is this described as administratively?

It is described as a discretionary NIH grant in the health funding category.

How much total funding was estimated for this announcement?

The estimated total funding listed for the announcement is $750,000.

When was the opportunity posted?

It was posted on May 23, 2011.

What was the application closing date?

The application closing date was August 2, 2011.

When was the archive date?

The archive date was September 2, 2011.

Where could applicants find the full official text and additional details?

The notice states that additional details and the full official text were available through the NIH grants guide page linked in the notice.

Who was listed for technical help if there were access or linking problems?

NIH Office of Extramural Research webmaster contacts were provided for access or linking problems.

Browse more business programs for Technology Service Providers

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: South Texas Refuge Complex Beyond the Boundaries

Previous opportunity: Technology Development for High Throughput Functional Genomics (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA HG 11 015

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA HG 11 015) also looked into and applied for these:

Funding Opportunity
ORAL HEALTH TRAINING AND TECHNICAL ASSISTANCE NATIONAL COOPERATIVE AGREEMENT Apply for HRSA 11 180

Funding Number: HRSA 11 180
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Mechanistic Studies of HIV exposed Seronegative Individuals (HESN)(R21) Apply for PA 11 217

Funding Number: PA 11 217
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Mechanistic Studies of HIV exposed Seronegative Individuals (HESN) (R01) Apply for PA 11 218

Funding Number: PA 11 218
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Predictive Biodosimetry Discovery and Development of Biomarkers for Acute and Delayed Radiation Injuries (R01) Apply for RFA AI 11 033

Funding Number: RFA AI 11 033
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
FY11 Campus Men Supporting Womens Health Project (CMSWHP) Apply for WH HPP 11 001

Funding Number: WH HPP 11 001
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $240,000
FY11 Health Care Provider Response to Violence Against Women Education, Training and Technical Assistance Program Apply for WH AST 11 001

Funding Number: WH AST 11 001
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $1,600,000
FY11 Faith Advocates for Health Relationships Training and Technical Assistance Project Apply for WH AST 11 002

Funding Number: WH AST 11 002
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $300,000
NIAMS Clinical Trial Implementation Cooperative Agreement (U01) Apply for PAR 11 219

Funding Number: PAR 11 219
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Strategies for the Protection of Pregnant Women and Infants Against Infectious Diseases (R01) Apply for RFA AI 11 036

Funding Number: RFA AI 11 036
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Limited Competition NIMHD Endowment Program for Increasing Research and Institutional Resources Capacity (S21) Apply for RFA MD 11 006

Funding Number: RFA MD 11 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Therapeutics for Neurotropic Biodefense Toxins and Pathogens (R21/R33) Apply for RFA AI 11 027

Funding Number: RFA AI 11 027
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
FY11 Announcement of Availability of Funds for Phase II of the Coalition for a Healthier Community Program Apply for WH CCE 11 001

Funding Number: WH CCE 11 001
Agency: Office of the Assistant Secretary for Health
Category: Health
Funding Amount: $300,000
Support of NIGMS Program Project Grants (P01) Apply for PAR 11 220

Funding Number: PAR 11 220
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
School Based Comprehensive Oral Health Services Grant Program Apply for HRSA 11 112

Funding Number: HRSA 11 112
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $200,000
Public Health Surveillance of Deep Vein Thrombosis and Pulmonary Embolism Apply for CDC RFA DD11 1109

Funding Number: CDC RFA DD11 1109
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $400,000
Developing Support and Educational Awareness for Young (45) Breast Cancer Survivors in the United States Apply for CDC RFA DP11 1111

Funding Number: CDC RFA DP11 1111
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $230,000
Affordable Care Act (ACA) Maternal, Infant and Early Childhood Home Visiting Program Apply for HRSA 11 179

Funding Number: HRSA 11 179
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Limited Competition NIMHD Revision Applications to Support Environmental Health Disparities Research (P60) Apply for RFA MD 11 008

Funding Number: RFA MD 11 008
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Limited Competition NIMHD Revision Applications to Support Environmental Health Disparities Research (P20) Apply for RFA MD 11 007

Funding Number: RFA MD 11 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Reducing the Impact of Hypertension in Low and Middle Income Countries (U01) Apply for RFA HL 12 027

Funding Number: RFA HL 12 027
Agency: National Institutes of Health
Category: Health
Funding Amount: $230,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA HG 11 015", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.